PMV Pharmaceuticals (PMVP) Stock: Why It's Up Today
Updated Oct 19, 2026, 4:00 PM ET · closing price
- Closed at $1.25, +3.72% vs the prior close of $1.21.
- Volume 195.93K shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PMVP jumps 3.7% to $1.25. Closed at $1.25, +3.72% vs the prior close of $1.21. Day range $1.21–$1.29, opened at $1.21.
PMVP daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — PMVP jumps 3.7% to $1.25
- Closed at $1.25, +3.72% vs the prior close of $1.21. Day range $1.21–$1.29, opened at $1.21.
- Volume was 195.93K shares, 0.3x its 50-day average of 745.18K — lighter than usual.
- Price is -8.8% vs its 50-day average ($1.38) and -3.2% vs its 200-day average ($1.30).
- 52-week range $1.02–$1.91; today's close sits at 26% of that range, 34.3% below the 52-week high.
Oct 16, 2026 — PMVP slides 6.2% to $1.21, a 1-month low
- Closed at $1.21, -6.20% vs the prior close of $1.29. Day range $1.20–$1.30, opened at $1.28.
- Volume was 357.04K shares, 0.5x its 50-day average of 740.51K — lighter than usual.
- Price is -11.9% vs its 50-day average ($1.37) and -6.6% vs its 200-day average ($1.30).
- 52-week range $1.02–$1.91; today's close sits at 21% of that range, 36.6% below the 52-week high.
Oct 15, 2026 — PMVP jumps 4.0% to $1.29
- Closed at $1.29, +4.03% vs the prior close of $1.24. Day range $1.24–$1.33, opened at $1.26.
- Volume was 376.60K shares, 0.5x its 50-day average of 735.73K — lighter than usual.
- Price is -6.1% vs its 50-day average ($1.37) and -0.5% vs its 200-day average ($1.30).
- 52-week range $1.02–$1.91; today's close sits at 30% of that range, 32.5% below the 52-week high.
Oct 14, 2026 — PMVP slides 8.1% to $1.24, a 1-month low, 3 down days in a row
- Closed at $1.24, -8.15% vs the prior close of $1.35. Day range $1.23–$1.37, opened at $1.33.
- Volume was 525.80K shares, 0.7x its 50-day average of 733.42K.
- Price is -9.6% vs its 50-day average ($1.37) and -4.3% vs its 200-day average ($1.30).
- 52-week range $1.02–$1.91; today's close sits at 25% of that range, 35.1% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — PMVP slides 4.3% to $1.35
- Closed at $1.35, -4.26% vs the prior close of $1.41. Day range $1.32–$1.47, opened at $1.40.
- Volume was 541.30K shares, 0.7x its 50-day average of 764.70K.
- Price is -1.4% vs its 50-day average ($1.37) and +4.2% vs its 200-day average ($1.30).
- 52-week range $1.02–$1.91; today's close sits at 37% of that range, 29.3% below the 52-week high.
Oct 12, 2026 — PMVP slides 7.2% to $1.41
- Closed at $1.41, -7.24% vs the prior close of $1.52. Day range $1.40–$1.55, opened at $1.55.
- Volume was 398.60K shares, 0.5x its 50-day average of 758.96K — lighter than usual.
- Price is +3.3% vs its 50-day average ($1.37) and +8.9% vs its 200-day average ($1.29).
- 52-week range $1.02–$1.91; today's close sits at 44% of that range, 26.2% below the 52-week high.
Oct 9, 2026 — PMVP rises 2.0% to $1.52
- Closed at $1.52, +2.01% vs the prior close of $1.49. Day range $1.48–$1.61, opened at $1.49.
- Volume was 891.70K shares, 1.2x its 50-day average of 750.75K.
- Price is +11.8% vs its 50-day average ($1.36) and +17.5% vs its 200-day average ($1.29).
- 52-week range $1.02–$1.91; today's close sits at 56% of that range, 20.4% below the 52-week high.
Oct 8, 2026 — PMVP dips 0.7% to $1.49, 4 down days in a row
- Closed at $1.49, -0.67% vs the prior close of $1.50. Day range $1.46–$1.54, opened at $1.51.
- Volume was 461.40K shares, 0.6x its 50-day average of 749.04K.
- Price is +10.3% vs its 50-day average ($1.35) and +15.3% vs its 200-day average ($1.29).
- 52-week range $1.02–$1.91; today's close sits at 53% of that range, 22.0% below the 52-week high.
- That makes 4 straight losses.
Oct 7, 2026 — PMVP slides 6.8% to $1.50, 3 down days in a row
- Closed at $1.50, -6.83% vs the prior close of $1.61. Day range $1.48–$1.60, opened at $1.59.
- Volume was 607.40K shares, 0.8x its 50-day average of 746.33K.
- Price is +11.7% vs its 50-day average ($1.34) and +16.2% vs its 200-day average ($1.29).
- 52-week range $1.02–$1.91; today's close sits at 54% of that range, 21.5% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — PMVP slides 9.6% to $1.61
- Closed at $1.61, -9.55% vs the prior close of $1.78. Day range $1.59–$1.81, opened at $1.78.
- Volume was 616.10K shares, 0.8x its 50-day average of 738.53K.
- Price is +20.6% vs its 50-day average ($1.33) and +24.8% vs its 200-day average ($1.29).
- 52-week range $1.02–$1.91; today's close sits at 66% of that range, 15.7% below the 52-week high.
Oct 5, 2026 — PMVP dips 0.6% to $1.78
- Closed at $1.78, -0.56% vs the prior close of $1.79. Day range $1.70–$1.84, opened at $1.80.
- Volume was 1.19M shares, 1.7x its 50-day average of 717.46K.
- Price is +34.2% vs its 50-day average ($1.33) and +38.2% vs its 200-day average ($1.29).
- 52-week range $1.02–$1.91; today's close sits at 85% of that range, 6.8% below the 52-week high.
- SEC filings that day: 8-K.
Oct 2, 2026 — PMVP rises 2.3% to $1.79, a 6-month high on 5.8x normal volume
- Closed at $1.79, +2.29% vs the prior close of $1.75. Day range $1.68–$1.87, opened at $1.75.
- Volume was 3.74M shares, 5.8x its 50-day average of 647.76K — unusually heavy trading.
- Price is +36.1% vs its 50-day average ($1.32) and +39.3% vs its 200-day average ($1.28).
- 52-week range $1.02–$1.91; today's close sits at 87% of that range, 6.3% below the 52-week high.
- That makes 5 straight gains.
PMVP bull case vs bear case (from the data)
- No clear positive signal in the price trend, filings or insider data right now.
- Price is -8.8% vs its 50-day average — short-term trend is down.
- Price is -3.2% vs its 200-day average — below the long-term trend line.
- Latest fiscal-year net income: loss of $77.74M.
- Insider selling outweighs buying: 8 sales vs 0 open-market buys among the 8 most recent reported insider trades (Form 4, last 12 months).
- High volatility: average daily move of 5.0% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
PMVP latest news & SEC filings
Every SEC filing by or about PMVP in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 5, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 15, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 8.01 — Reported other events the company considers important.
Sep 2, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 31, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 31, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 31, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$18.09M (prior year -$21.21M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.34 (prior year -$0.41) (loss narrowed vs Jun 30, 2025)
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 28, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 10, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade PMVP
- Last results release: Aug 14, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Mar 6, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 13, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.95% (largest 16.8%). That is a volatile stock.
- Liquidity: about 859.89K shares (≈$1.08M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.25 vs a range of $1.02–$1.91 (26% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 8 sales; latest: Capital Gp V Llc Orbimed sold 1,000,000 shares on Oct 23, 2025.
- Latest filings: 8-K Oct 5, 2026; 8-K Sep 2, 2026; 8-K Aug 31, 2026.
- Share count: 53.46M shares outstanding (Aug 14, 2026), +0.9% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
PMVP market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 1.21 | 1.29 | 1.21 | 1.25 | 195.93K |
| Oct 16, 2026 | 1.28 | 1.30 | 1.20 | 1.21 | 357.60K |
| Oct 15, 2026 | 1.26 | 1.33 | 1.24 | 1.29 | 376.60K |
| Oct 14, 2026 | 1.33 | 1.37 | 1.23 | 1.24 | 525.80K |
| Oct 13, 2026 | 1.40 | 1.47 | 1.32 | 1.35 | 541.30K |
| Oct 12, 2026 | 1.55 | 1.55 | 1.40 | 1.41 | 398.60K |
| Oct 9, 2026 | 1.49 | 1.61 | 1.48 | 1.52 | 891.70K |
| Oct 8, 2026 | 1.51 | 1.54 | 1.46 | 1.49 | 461.40K |
| Oct 7, 2026 | 1.59 | 1.60 | 1.48 | 1.50 | 607.40K |
| Oct 6, 2026 | 1.78 | 1.81 | 1.59 | 1.61 | 616.10K |
| Oct 5, 2026 | 1.80 | 1.84 | 1.70 | 1.78 | 1.19M |
| Oct 2, 2026 | 1.75 | 1.87 | 1.68 | 1.79 | 3.74M |
| Oct 1, 2026 | 1.68 | 1.91 | 1.63 | 1.75 | 1.65M |
| Sep 30, 2026 | 1.44 | 1.73 | 1.44 | 1.67 | 3.12M |
| Sep 29, 2026 | 1.37 | 1.45 | 1.36 | 1.43 | 550.90K |
| Sep 28, 2026 | 1.34 | 1.39 | 1.30 | 1.36 | 336.10K |
| Sep 25, 2026 | 1.32 | 1.38 | 1.29 | 1.33 | 271.20K |
| Sep 24, 2026 | 1.36 | 1.40 | 1.28 | 1.34 | 486.30K |
| Sep 23, 2026 | 1.51 | 1.52 | 1.37 | 1.37 | 570.70K |
| Sep 22, 2026 | 1.47 | 1.52 | 1.46 | 1.51 | 316.90K |
About PMV Pharmaceuticals
PMV Pharmaceuticals (PMVP) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in PRINCETON, NJ. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1699382.
PMVP board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Charles M Baum | Director | Jun 5, 2026 |
| Kirsten Flowers | Director | Jun 5, 2026 |
| Carol Giltner Gallagher | Director | Jun 5, 2026 |
| Arnold J Levine | Director | Jun 5, 2026 |
| David Henry Mack | President and CEO | Mar 9, 2026 |
| Laurie Stelzer | Director | Jun 5, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Michael Carulli | Chief Financial Officer | Mar 9, 2026 |
| Deepika Jalota | Chief Development Officer | Mar 9, 2026 |
| David Henry Mack | President and CEO | Mar 9, 2026 |
| Robert Ticktin | General Counsel & COO | Mar 9, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Oct 23, 2025 | Capital Gp V Llc Orbimed | Sale | 1,000,000 | $1.52 |
| Oct 23, 2025 | Capital Gp V Llc Orbimed | Sale | 1,000,000 | $1.52 |
| Oct 23, 2025 | Advisors Llc Orbimed | Sale | 1,000,000 | $1.52 |
| Oct 23, 2025 | Advisors Llc Orbimed | Sale | 1,000,000 | $1.52 |
| Oct 23, 2025 | Capital Gp V Llc Orbimed | Sale | 1,000,000 | $1.52 |
| Oct 23, 2025 | Capital Gp V Llc Orbimed | Sale | 1,000,000 | $1.52 |
| Oct 23, 2025 | Advisors Llc Orbimed | Sale | 1,000,000 | $1.52 |
| Oct 23, 2025 | Advisors Llc Orbimed | Sale | 1,000,000 | $1.52 |
PMVP financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-77.74M | -1.48 | $-73.58M |
| Dec 31, 2024 | — | $-58.71M | -1.14 | $-51.28M |
| Dec 31, 2023 | — | $-68.96M | -1.44 | $-55.66M |
| Dec 31, 2022 | — | $-73.32M | -1.61 | $-63.76M |
| Dec 31, 2021 | — | $-57.85M | -1.28 | $-46.57M |
Latest balance sheet: total assets $82.07M, total liabilities $10.57M, cash $12.47M (as of Jun 30, 2026).
PMVP earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 14, 2026 | 8-K Item 2.02 (results) | $1.26 |
| May 12, 2026 | 8-K Item 2.02 (results) | $1.42 |
| Mar 6, 2026 | 8-K Item 2.02 (results) | $1.64 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $1.42 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $1.45 |
| May 9, 2025 | 8-K Item 2.02 (results) | $0.88 |
| Mar 3, 2025 | 8-K Item 2.02 (results) | $1.32 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $1.78 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Feb 29, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on PMVP
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.